MedPath

Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia

Recruiting
Conditions
Hemodynamic Instability
Hypovolemia
Registration Number
NCT03592290
Lead Sponsor
Yale University
Brief Summary

To monitor the changes in central and peripheral monitors/waveforms during gradual hypovolemia induced by lower body negative pressure in healthy volunteers.

Detailed Description

The primary aim of this research is to identify the most robust site for monitoring hypovolemia as well as assess changes in peripheral waveforms monitored by the pulse oximeter collected from different sites (finger, ear, forehead, and nose), blood pressure, cerebral oximetry and peripheral venous pressure during gradual hypovolemia induced by lower body negative pressure (LBNP) in healthy volunteers.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria

* Healthy volunteers aged 20-45 with

Read More
Exclusion Criteria
  • Pregnant women
  • Under 20 years of age
  • Subjects with coronary artery disease, diabetes, epilepsy and hypertension
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identify the most robust site for monitoring hypovolemia utilizing pulse oximeter waveforms.2 years

Data will be summarized using mean (SD) for normally distributed data, median (interquartile range) for non-normal data.

linear regression method will be used to model the changes of our dependent variable from baseline during blood loss.

Secondary Outcome Measures
NameTimeMethod
Examine the relationship between central hemodynamic changes (cardiac output) with changes in respiratory variability of PPG waveforms collected from different sites during hypovolemia and fluid resuscitation2 years

Data will be summarized using mean (SD) for normally distributed data, median (interquartile range) for non-normal data.

linear regression method will be used to model the changes of our dependent variable from baseline during blood loss.

Trial Locations

Locations (1)

John B. Pierce Laboratory

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath